ZA872230B - Compounds having a cognition adjuvant action,agents containing them,and the use thereof for the treatment and prophylaxis of cognitive dysfunctions - Google Patents

Compounds having a cognition adjuvant action,agents containing them,and the use thereof for the treatment and prophylaxis of cognitive dysfunctions

Info

Publication number
ZA872230B
ZA872230B ZA872230A ZA872230A ZA872230B ZA 872230 B ZA872230 B ZA 872230B ZA 872230 A ZA872230 A ZA 872230A ZA 872230 A ZA872230 A ZA 872230A ZA 872230 B ZA872230 B ZA 872230B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
treatment
compounds
agents containing
cognitive dysfunctions
Prior art date
Application number
ZA872230A
Other languages
English (en)
Inventor
Hock Franz
Scholtholt Josef
Urbach Hansjoerg
Henning Rainer
Lerch Ulrich
Nickel Wolf-Ulrich
Rueger Wolfgang
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of ZA872230B publication Critical patent/ZA872230B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Epoxy Compounds (AREA)
ZA872230A 1986-03-27 1987-03-26 Compounds having a cognition adjuvant action,agents containing them,and the use thereof for the treatment and prophylaxis of cognitive dysfunctions ZA872230B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (de) 1986-03-27 1986-03-27 Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen

Publications (1)

Publication Number Publication Date
ZA872230B true ZA872230B (en) 1987-09-21

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872230A ZA872230B (en) 1986-03-27 1987-03-26 Compounds having a cognition adjuvant action,agents containing them,and the use thereof for the treatment and prophylaxis of cognitive dysfunctions

Country Status (25)

Country Link
EP (1) EP0243645B1 (ko)
JP (1) JPS62240698A (ko)
KR (1) KR870008841A (ko)
CN (1) CN1031267C (ko)
AT (1) ATE102954T1 (ko)
AU (1) AU621278B2 (ko)
CA (1) CA1341064C (ko)
CS (2) CS651989A3 (ko)
DD (1) DD280765A5 (ko)
DE (2) DE3610391A1 (ko)
DK (1) DK172221B1 (ko)
EG (1) EG18175A (ko)
ES (1) ES2061447T3 (ko)
FI (1) FI91876C (ko)
HU (2) HU203117B (ko)
IE (1) IE62456B1 (ko)
MA (1) MA20919A1 (ko)
NO (1) NO178546C (ko)
NZ (1) NZ219764A (ko)
OA (1) OA08506A (ko)
PH (1) PH27210A (ko)
PT (1) PT84564B (ko)
RU (1) RU1836335C (ko)
TN (1) TNSN87045A1 (ko)
ZA (1) ZA872230B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
AU612137B2 (en) * 1987-04-27 1991-07-04 E.R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (de) * 1987-09-16 1989-04-06 Hoechst Ag Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE3801587A1 (de) * 1988-01-21 1989-08-03 Hoechst Ag Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0331609A3 (de) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung
DE3803225A1 (de) * 1988-02-04 1989-08-17 Hoechst Ag Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
JP2004532200A (ja) * 2001-03-15 2004-10-21 サエジス ファーマシューティカルズ， インコーポレイテッド 全身性ストレスの後に認識機能を回復するための方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19575012I2 (de) * 1980-10-23 2002-01-24 Schering Corp Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3300774A1 (de) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
CS212687A3 (en) 1992-04-15
NZ219764A (en) 1990-11-27
PT84564B (pt) 1989-11-10
HU896609D0 (en) 1990-02-28
ES2061447T3 (es) 1994-12-16
NO871282L (no) 1987-09-28
EP0243645A2 (de) 1987-11-04
DE3789330D1 (de) 1994-04-21
DK153587D0 (da) 1987-03-26
AU7064987A (en) 1987-10-01
IE62456B1 (en) 1995-02-08
OA08506A (fr) 1988-07-29
NO871282D0 (no) 1987-03-26
CS276385B6 (en) 1992-05-13
FI871304A (fi) 1987-09-28
EG18175A (en) 1994-07-30
CN1031267C (zh) 1996-03-13
DK172221B1 (da) 1998-01-12
HU202118B (en) 1991-02-28
KR870008841A (ko) 1987-10-21
MA20919A1 (fr) 1987-10-01
CA1341064C (en) 2000-08-01
IE870784L (en) 1987-09-27
JPS62240698A (ja) 1987-10-21
ATE102954T1 (de) 1994-04-15
CS276179B6 (en) 1992-04-15
CS651989A3 (en) 1992-05-13
DD280765A5 (de) 1990-07-18
NO178546B (no) 1996-01-08
PH27210A (en) 1993-05-04
RU1836335C (ru) 1993-08-23
EP0243645B1 (de) 1994-03-16
HU203117B (en) 1991-05-28
NO178546C (no) 1996-04-17
EP0243645A3 (en) 1990-01-24
FI871304A0 (fi) 1987-03-25
CN87102304A (zh) 1987-12-30
PT84564A (de) 1987-04-01
TNSN87045A1 (fr) 1990-01-01
FI91876C (fi) 1994-08-25
FI91876B (fi) 1994-05-13
AU621278B2 (en) 1992-03-12
DK153587A (da) 1987-09-28
DE3610391A1 (de) 1987-10-08
HUT46046A (en) 1988-09-28

Similar Documents

Publication Publication Date Title
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
ZA872230B (en) Compounds having a cognition adjuvant action,agents containing them,and the use thereof for the treatment and prophylaxis of cognitive dysfunctions
GB8801306D0 (en) Chemical compounds
GR860571B (en) Labdan-derivatives process for their preparation and their use as medicaments
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
ZA886459B (en) Use of bezafibrate for treating diabetes
GR3004959T3 (ko)
GB8823605D0 (en) Therapeutic agents
CA1268468C (en) PROSTAGLANDIN ANALOGS WITH SUBSTITUTE THIABICYCLOHEPTAN GROUP
JO1516B1 (en) Compounds with cognitive effectiveness, factors containing them, and their use in treatment and disease prevention for cognitive dysfunction
ZA86365B (en) Use of sulphanyldihydropyridines as medicaments for the treatment of asthma
EP0257631A3 (en) Oxolabdanes, a process for their preparation and their use as medicaments
MTP1001B (en) Compounds having a cognition adjuvant action,agents containing them,and the use of there of for treatment and prophylaxis of cognitive dysfunctions (hoe 86/f069)
EP0254068A3 (en) Novel therapeutic agent for gastritis
GB8729067D0 (en) Treatment of timber
ZA882737B (en) Antiasthmatic agent
GB8602474D0 (en) Treatment for timber